(Q42550027)

English

Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer

scientific article published on January 1997

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

2 November 2017

Combination chemotherapy with cyclophosphamide, vincristine, adriamycin, and dexamethasone (CVAD) plus oral quinine and verapamil in patients with advanced breast cancer (English)

1 reference

Europe PubMed Central

2 November 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

4

object named as

Dorr RT

1 reference

Europe PubMed Central

2 November 2017

Sydney E. Salmon

5

object named as

Salmon SE

1 reference

Europe PubMed Central

2 November 2017

author name string

Taylor CW

1

1 reference

Europe PubMed Central

2 November 2017

Dalton WS

2

1 reference

Europe PubMed Central

2 November 2017

Mosley K

3

1 reference

Europe PubMed Central

2 November 2017

language of work or name

0 references

publication date

1 January 1997

1 reference

Europe PubMed Central

2 November 2017

Breast Cancer Research and Treatment

1 reference

Europe PubMed Central

2 November 2017

42

1 reference

Europe PubMed Central

2 November 2017

1

1 reference

Europe PubMed Central

2 November 2017

7-14

1 reference

Europe PubMed Central

2 November 2017

https://scigraph.springernature.com/pub.10.1023/a:1005716214718

0 references

Multiple-drug resistance in human cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Electrophoretic analysis of 248 clinical breast cancer specimens for P-glycoprotein overexpression or gene amplification.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

P-glycoprotein expression in treated and untreated human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

P-glycoprotein expression in primary breast cancer detected by immunocytochemistry with two monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Different mechanisms of decreased drug accumulation in doxorubicin and mitoxantrone resistant variants of the MCF7 human breast cancer cell line

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Prediction of doxorubicin resistance in vitro in myeloma, lymphoma, and breast cancer by P-glycoprotein staining

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Transgenic mice that express the human multidrug-resistance gene in bone marrow enable a rapid identification of agents that reverse drug resistance

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Quantitation of differential sensitivity of human-tumor stem cells to anticancer drugs

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Drug-resistance in multiple myeloma and non-Hodgkin's lymphoma: detection of P-glycoprotein and potential circumvention by addition of verapamil to chemotherapy.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Randomized phase II study of single-agent epirubicin +/- verapamil in patients with advanced metastatic breast cancer. An AIO clinical trial. Arbeitsgemeinschaft Internistische Onkologie of the German Cancer Society.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

21 January 2018

Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

7 January 2021

based on heuristic

inferred from DOI database lookup

Clinical Relevance of Immunohistochemical Detection of Multidrug Resistance P-Glycoprotein in Breast Carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

7 January 2021

based on heuristic

inferred from DOI database lookup

P-glycoprotein expression in malignant lymphoma and reversal of clinical drug resistance with chemotherapy plus high-dose verapamil

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

7 January 2021

based on heuristic

inferred from DOI database lookup

Quinidine as a resistance modulator of epirubicin in advanced breast cancer: mature results of a placebo-controlled randomized trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1005716214718

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1023/A:1005716214718

1 reference

Europe PubMed Central

2 November 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

2 November 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42550027&oldid=2076600026"